Type 2 diabetes mellitus with HbA1c > 7.5 %
Body mass index > 35 and < 50 kg/m2
Candidate for Gastric By-Pass
Treatment with GLP1 (glucagon-like peptide) analogue or insulin

NCT01501201_inc_T1
Condition
Type 2 diabetes mellitus
NCT01501201_inc_T2
Measurement
HbA1c
NCT01501201_inc_T3
Value
> 7.5 %
NCT01501201_inc_T4
Measurement
Body mass index
NCT01501201_inc_T5
Value
> 35 and < 50 kg/m2
NCT01501201_inc_T6
Procedure
Gastric By-Pass
NCT01501201_inc_T7
Mood
Candidate
NCT01501201_inc_T8
Drug
GLP1 (glucagon-like peptide) analogue
NCT01501201_inc_T9
Drug
insulin
NCT01501201_inc_T10
Procedure
Treatment
NCT01501201_inc_T11
Scope
GLP1 (glucagon-like peptide) analogue or insulin